Search for "transition metal complexes" in Full Text gives 97 result(s) in Beilstein Journal of Organic Chemistry.
Beilstein J. Org. Chem. 2013, 9, 2129–2136, doi:10.3762/bjoc.9.250
Graphical Abstract
Scheme 1: Retro synthetic approach for the construction of N-(2,3-dihydroxypropyl)arylamides.
Scheme 2: Synthesis of phthalimido-protected chiral hydroxypropyl benzoate.
Scheme 3: Proposed mechanism of epoxide opening.
Scheme 4: Reagents and conditions: (a) Methylamine, DCM, 30–35 °C, 94%.
Beilstein J. Org. Chem. 2013, 9, 1352–1382, doi:10.3762/bjoc.9.153
Graphical Abstract
Figure 1: Qualitative orbital diagram for a d8 metal in ML4 square-planar and ML3 T-shaped complexes.
Figure 2: Walsh diagram for the d-block of a d8 ML3 complex upon bending of one L–M–L angle.
Figure 3: Neutral Y-shaped Pt complex Y1 [15]. Angles are given in degrees.
Figure 4: General classification of T-shaped Pt(II) structures according to the fourth coordination site.
Figure 5: Hydride, boryl and borylene true T-shaped Pt(II) complexes.
Figure 6: NHC-based true T-shaped Pt(II) complexes.
Figure 7: Phosphine-based agostic T-shaped Pt(II) complexes. Compounds in brackets correspond with hydrido–al...
Figure 8: Phenylpyridine and NHC-based agostic T-shaped Pt(II) complexes.
Figure 9: Counteranion coordination in T-shaped Pt(II) complexes.
Figure 10: Phosphine-based solvento Pt(II) complexes.
Figure 11: Nitrogen-based solvento Pt(II) complexes.
Figure 12: Pincer-based solvento Pt(II) complexes.
Figure 13: Structure of the QM/MM optimized cisplatin–protein adduct [94].
Figure 14: NMR coupling constants used for the characterization of three-coordinate Pt(II) species.
Figure 15: The chemical formula of the complexes discussed in Table 2.
Scheme 1: Halogen abstraction from 1.
Scheme 2: Halogen abstraction from 2 forming the dicationic complex T3 [22].
Scheme 3: Hydrogenation of complexes A5a and A5b [39].
Scheme 4: Hydrogenation of complexes 3 and A5c [40].
Scheme 5: Intermolecular C–H bond activation from T5a [28].
Scheme 6: Protonation of complexes 4 [35,36].
Scheme 7: Cyclometalation of 5 [43].
Scheme 8: Protonation of 6.
Scheme 9: Reductive elimination of ethane from 7.
Scheme 10: Reductive elimination of methane from six-coordinate Pt(IV) complexes.
Scheme 11: Proposed dissociative mechanism for the fluxional motion of dmphen in [Pt(Me)(dmphen)(PR3)]+ comple...
Figure 16: Feasible interactions for unsaturated intermediates 11b (left) and 12b (right) during fluxional mot...
Scheme 12: Halogen abstraction from 13a,b and subsequent cyclometalation to yield complexes A5a,b [39].
Scheme 13: Proposed mechanism for the acid-catalyzed cyclometalation of 14 via intermediate 15 [41].
Scheme 14: Proposed mechanism for the formation of 19 [102].
Scheme 15: Cyclometalation of 20 via thioether dissociation [117].
Figure 17: Gibbs energy profile (in chloroform solvent) for the cyclometalation of 23 [120].
Scheme 16: Coordination of tmtu to 29 and subsequent C–H bond activation via three-coordinate species 31 and 32...
Scheme 17: Cyclometalation process of NHC-based Pt(II) complexes [28,44].
Scheme 18: Cyclometalation process of complex A9 [43].
Scheme 19: “Rollover” reaction of 38 and subsequent oligomerization [123].
Scheme 20: Proposed mechanism for the formation of cyclometalated species 44 [124].
Scheme 21: Self-assembling process of 45 by “rollover” reaction [126].
Scheme 22: “Rollover” reaction of A9. Energies (solvent) in kcal mol−1 [127].
Scheme 23: Proposed mechanisms for the “rollover” cyclometalation of 52 in gas-phase ion-molecule reactions [128].
Scheme 24: β-H elimination and 1,2-insertion equilibrium involving A1d and the subsequent generation of 57 [35].
Scheme 25: Proposed mechanism for thermolysis of 7b and 7c in benzene-d6 and cyclohexane-d12 solvents [101].
Scheme 26: β-H elimination process of A11a [28].
Scheme 27: Intermolecular C–H bond activation from 62 [95].
Scheme 28: Reductive elimination of methane from 65 followed by CD3CN coordination or C–D bond-activation proc...
Figure 18: DFT-optimized structures describing the κ2 (69, left) and κ3 (69’, right) coordination modes of [Pt...
Scheme 29: Intermolecular arene C–H bond activation from NHC-based complexes [28].
Figure 19: Energy profiles (in benzene solvent) for the benzene C–H bond activation from A11a, A11b, T5a and T...
Scheme 30: Intermolecular arene C–H bond activation from PNP-based complex 71 [12].
Scheme 31: Intermolecular C–H bond-activation by gas-phase ion-molecule reactions of 74 [7,142].
Scheme 32: Dihydrogen activation through complexes A5a, A5b [39], A5c [40] and S1a [54].
Scheme 33: Dihydrogen activation through complexes A7 and 16 [41]. For a: see Scheme 13.
Scheme 34: Br2 and I2 bond activations through complexes A11a and T5a [143].
Scheme 35: Detection and isolation of the Pt(III) complex 81a [143].
Scheme 36: Cl2 bond activation through complexes 82 and 83 [144].
Scheme 37: cis–trans Isomerization mechanism of the solvento Pt(II) complexes S5 [2,61].
Figure 20: Energy profiles for the isomerization of complexes [Pt(R)(PMe3)2(NCMe)]+ where R means Me (85a, red...
Figure 21: DFT-optimized structure of intermediate 86 [62]. Bond distances in angstrom and angles in degrees.
Scheme 38: Proposed dissociative ligand-substitution mechanism of cis-[Pt(R)2S2] complexes (87) [117].
Scheme 39: Proposed mechanisms for the ligand substitution of the dinuclear species 91 [146].
Beilstein J. Org. Chem. 2013, 9, 1296–1310, doi:10.3762/bjoc.9.146
Graphical Abstract
Scheme 1: Catalytic role of NHPI in the selective oxidation of organic substrates.
Scheme 2: Radical addition of aldehydes and analogues to alkenes.
Scheme 3: NHPI/AIBN-promoted aerobic oxidation of 2,6-diisopropylnaphthalene.
Scheme 4: NHPI/AIBN-promoted aerobic oxidation of CHB.
Scheme 5: NMBHA/MeOAMVN promoted aerobic oxidation of PUFA.
Scheme 6: Alkene dioxygenation by means of N-aryl hydroxamic acid and O2.
Scheme 7: NHPI-catalyzed reaction of adamantane under NO atmosphere.
Scheme 8: Nitration of alkanes and alkyl side-chains of aromatics.
Scheme 9: Radical mechanism for the nitration of alkanes catalyzed by NHPI.
Scheme 10: Benzyl alcohols from alkylbenzenes.
Scheme 11: Catalytic cycle of laccase-NHDs mediator oxidizing system.
Figure 1: Mediators of laccase.
Scheme 12: DADCAQ/NHPI-mediated aerobic oxidation mechanism.
Scheme 13: DADCAQ/TCNHPI mediated aerobic oxidation of ethylbenzene.
Scheme 14: NHPI/xanthone/TMAC mediated aerobic oxidation of ethylbenzene.
Scheme 15: NHPI/AQ-mediated aerobic oxidation of α-isophorone.
Scheme 16: NHPI/AQ-mediated oxidation of cellulose fibers by NaClO/NaBr system.
Scheme 17: NHPI/AQ mediated aerobic oxidation of cellulose fibers.
Scheme 18: Molecule-induced homolysis by peracids.
Scheme 19: Molecule-induced homolysis of NHPI/m- chloroperbenzoic acid system.
Scheme 20: Proposed mechanism for the NHPI/CH3CHO/O2-mediated epoxidation.
Scheme 21: NHPI/CH3CHO-mediated aerobic oxidation of alkyl aromatics.
Scheme 22: Light-induced generation of PINO from N-alkoxyphthalimides.
Scheme 23: Visible-light/g-C3N4 induced metal-free oxidation of allylic substrates.
Scheme 24: NHPI/o-phenanthroline-mediated organocatalytic system.
Scheme 25: NHPI/DMG-mediated organocatalytic system.
Scheme 26: NHPI catalyzed oxidative cleavage of C=C bonds.
Scheme 27: Synthesis of hydrazine derivatives.
Beilstein J. Org. Chem. 2013, 9, 1192–1193, doi:10.3762/bjoc.9.134
Beilstein J. Org. Chem. 2013, 9, 1141–1147, doi:10.3762/bjoc.9.127
Graphical Abstract
Scheme 1: Photoinduced radical reaction of diaryl diselenide with triphenylbismuthine.
Scheme 2: Photoinduced reaction of diphenyl disulfide with triphenylbismuthine.
Scheme 3: A plausible reaction pathway for the photoinduced reaction of diaryl diselenide with triarylbismuth...
Beilstein J. Org. Chem. 2013, 9, 866–876, doi:10.3762/bjoc.9.100
Graphical Abstract
Scheme 1: Synthesis of 4'-ethynyl-2,2':6',2''-terpyridine (5).
Scheme 2: Synthesis of tpy-functionalized dendritic oligothiophenes 8 and 9.
Scheme 3: Synthesis of homoleptic Ru(II) complexes 1 and 2.
Figure 1: (a) Absorption spectra of ligands and their corresponding Ru(II)-dendrimers in acetonitrile solutio...
Figure 2: Electronic distribution of the frontier orbitals (HOMO, HOMO-1 and LUMO) for complexes 1 (a) and 2 ...
Figure 3: CV of 1.0 mM solutions of ligands (a) and complexes (b) in anhydrous dichloromethane (oxidation) an...
Beilstein J. Org. Chem. 2013, 9, 698–704, doi:10.3762/bjoc.9.79
Graphical Abstract
Figure 1: Structure of Pd complexes 1–4.
Scheme 1: Synthesis of Pd complexes 1 and 2.
Figure 2: ORTEP representation of the structure of complex 1 in the crystal (35% probability ellipsoids). Hyd...
Figure 3: ORTEP representation of the structure of complex 2 in the crystal (35% probability ellipsoids). Hyd...
Scheme 2: Multiple Suzuki–Miyaura coupling of polybromoarenes using complex 1.
Beilstein J. Org. Chem. 2013, 9, 342–391, doi:10.3762/bjoc.9.39
Graphical Abstract
Figure 1: Change of electron distribution between HS and LS states of an octahedral iron(II) coordination com...
Figure 2: Types of spin transition curves in terms of the molar fraction of HS molecules, γHS(T), as a functi...
Figure 3: Single crystal UV–vis spectra of the spin crossover compound [Fe(ptz)6](BF4)2 (ptz = 1-propyltetraz...
Figure 4: Thermal spin crossover in [Fe(ptz)6](BF4)2 (ptz = 1-propyltetrazole) recorded at three different te...
Figure 5: (a) Mössbauer spectra of the LS compound [Fe(phen)3]X2 recorded over the temperature range 300–5 K....
Figure 6: (left) Demonstration of light-induced spin state trapping (LIESST) in [Fe(ptz)6]BF4)2 with 57Fe Mös...
Figure 7: Schematic representation of the pressure influence (p2 > p1) on the LS and HS potential wells of an...
Figure 8: χMT versus T curves at different pressures for [Fe(phen)2(NCS)2], polymorph II. (Reproduced with pe...
Figure 9: Molecular structure (a) and γHS(T) curves at different pressures for [CrI2(depe)2] (b) (Reproduced ...
Figure 10: HS molar fraction γHS versusT at different pressures for [Fe(phy)2](BF4)2. The hysteresis loop broa...
Figure 11: Proposed structure of the polymeric [Fe(4R-1,2,4-triazole)3]2+ spin crossover cation (a) and plot o...
Figure 12: Temperature dependence of the HS fraction γHS(T), determined from Mössbauer spectra of [Fe(II)xZn1-x...
Figure 13: Influence of the noncoordinated anion on the spin transition curve γHS(T) near the transition tempe...
Figure 14: Spin transition curves γHS(T) for different solvates of the SCO complexes. [Fe(II)(2-pic)3]Cl2·Solv...
Figure 15: ST curves γHS(T) of the deuterated solvates of [Fe(II)(2-pic)3]Cl2·Solv with Solv = C2D5OH and C2H5...
Figure 16: Sketch of the two-step spin transition; [LS–LS] pair is diamagnetic, [LS–HS] is paramagnetic and th...
Figure 17: (left) Temperature dependence of χMT for {[Fe(L)(NCX)2]2bpym}(L = bpym or bt and X = S or Se). (rig...
Figure 18: Temperature dependence of χMT for [bpym, NCS−] (left) and [bpym, NCSe−] (right) at different pressu...
Figure 19: 57Fe Mössbauer spectra of [bpym, NCSe−] measured at 4.2 K at zero field (a) and at 5 T (b) (see tex...
Figure 20: Temperature dependence of χMT for [Fe2(L)3](ClO4)4·2H2O showing a complete two-step spin conversion...
Figure 21: (a) View of the dinuclear unit in the crystal structure of [Fe2(Hsaltrz)5(NCS)4]·4MeOH. (b) Tempera...
Figure 22: (left) AFM pattern recorded in tapping mode at room temperature on hexagonal single crystals of [Fe3...
Figure 23: (right) Stepwise SCO in an Fe4 [2 × 2] grid, which reveals a smooth magnetic profile under ambient ...
Figure 24: (left) View of the discrete nanoball made of Fe(II) SCO units as well as Cu(I) building blocks. (ri...
Figure 25:
(left) Linear dependency between T1/2 in the heating (Δ) and cooling () modes versus the anion volu...
Figure 26: (left) View of the linear chain structure of [Fe(1,2-bis(tetrazol-1-yl)propane)3]2+ along the a axi...
Figure 27: (left) View of the 2D layered structure of [Fe(btr)2(NCS)2]·H2O (at 293 K). The water molecules (in...
Figure 28: (left) Three interpenetrated square networks for [Fe(bpb)2(NCS)2]·MeOH. (right) χMT versus T plot s...
Figure 29: Part of the crystal structure of [Fe{N(entz)3}](BF4)2 (T = 293 K) [335,336]. (Reproduced with permission fro...
Figure 30: (left) Projection of the crystal structure of [Fe(btr)3](ClO4)2 along the c axis revealing a 3D str...
Figure 31: Size-dependent SCO properties in [Fe(pz)Pt(CN)4] (left), change of color upon spin state transition...
Figure 32: Schematic showing the epitaxial growth of polymer {Fe(pz)[Pt(CN)4]} and the spin transition propert...
Figure 33: Microcontact printing (μCP) of nanodots on Si-wafer of [Fe(ptz)6](BF4)2 after deposition of crystal...
Figure 34: (left) Projection of the two independent cations of [Fe(C6–trenH)]2+ with atom numbering scheme (15...
Figure 35: (a) χMT versus T for [Fe(C16-trenH)]Cl2·0.5H2O and variation of the distance d with temperature (T)...
Figure 36: Schematic illustration of the structure of compounds [Fe(Cn-tba)3]X2 adopting a columnar mesophase ...
Figure 37: Temperature dependence of the magnetic moment (M) at 1000 Oe and DSC profiles (inset; 5 °C/min) of ...
Figure 38: Porous structure of the SCO-PMOFs {Fe(pz)[M(II)(CN)4]} (left), representation of the host–guest int...
Figure 39: Porous structure of the guest-free SCO-PMOF’s {Fe(pz)[M(II)(CN)4]} (left), magnetic properties of t...
Figure 40: (left) The 3D porous structure of {Fe(pz)[Pt(CN)4]}·0.5(CS(NH2)2) (1) and {Fe(pz)[Pd(CN)4]}·1.5H2O·...
Figure 41: Top: The 3D porous structure of {Fe(dpe)[Pt(CN)4]}·phenazine in a direction close to [101] emphasiz...
Figure 42: View of the segregated stacking of [Ni(dmit)2]− and [Fe(sal2-trien)]+ in [Fe(qsal)2][Ni(dmit)2]3·CH3...
Figure 43: Thin films based on Fe(III) compounds coordinated to Terthienyl-substituted QsalH ligands [434] together...
Figure 44: Left: Temperature-dependent emission spectra for [Fe2(Hsaltrz)5(NCS)4]·4MeOH at λex = 350 nm over t...
Beilstein J. Org. Chem. 2012, 8, 1385–1392, doi:10.3762/bjoc.8.160
Graphical Abstract
Figure 1: An assortment of natural products synthesized by Diels–Alder reactions.
Figure 2: Intermediates towards the total synthesis of (−)-Δ9-tetrahydrocannabinol (4).
Scheme 1: Synthesis of thiourea catalysts 9a–l.
Scheme 2: Organocatalytic Diels–Alder reaction with thiourea-catalysis.
Figure 3: Formation of the iminium-ion.
Scheme 3: Synthesis of electron poor imidazolidinone catalysts.
Figure 4: Crystal structure of the side product from the reaction of 13.
Figure 5: Confirmation of the relative configuration with NOESY experiments and X-ray crystal structures of t...
Scheme 4: Co-catalyst screening.
Scheme 5: Screening of imidazolidinone catalysts 15.
Beilstein J. Org. Chem. 2012, 8, 1059–1070, doi:10.3762/bjoc.8.118
Graphical Abstract
Figure 1: Known types of η6-tricarbonylchromium complexes of sugar derivatives [9-13].
Scheme 1: Synthesis of glucoside 1l.
Scheme 2: Deprotection of 2c and enzymatic cleavage of 3.
Figure 2: ORTEP-plot of the asymmetric unit containing two molecules of compound 2a showing 30% probability e...
Figure 3: ORTEP-plot of the asymmetric unit showing two molecules of compound 2b and 30% probability ellipsoi...
Figure 4: ORTEP-plot of the asymmetrical unit showing two molecules of compound 2c and 30% probability ellips...
Figure 5: ORTEP-plot of the asymmetric unit showing two molecules of compound 2d and 30% probability ellipsoi...
Figure 6: ORTEP-plot of the asymmetrical unit showing two molecules of compound 2e and 30% probability ellips...
Figure 7: ORTEP-plot of the asymmetric unit showing three molecules of compound 2j and 30% probability ellips...
Figure 8: ORTEP-plot of the asymmetric unit showing three molecules of compound 2k and 30% probability ellips...
Figure 9: ORTEP-plot of the asymmetric unit showing two molecules of compound pR-2m and 30% probability ellip...
Figure 10: ORTEP-plot of the asymmetric unit showing three molecules of compound pS-2m and 30% probability ell...
Beilstein J. Org. Chem. 2012, 8, 951–957, doi:10.3762/bjoc.8.107
Graphical Abstract
Figure 1: First (2) and second (3) generation of dendrimers based on chiral C2-symmetric pyrrolidine 1 and ha...
Scheme 1: Use of the key intermediate (3S,4S)-1-benzyl-3,4-dihydroxypyrrolidine (6) [31] for the synthesis of pyr...
Scheme 2: Synthesis of calixarene-based dendrimers 2 and 3. Reagents and conditions: DIPEA, CH2Cl2, 30 °C, 5 ...
Figure 2: Expansion (about 7 to 3 ppm) of the 1H NMR spectra of (A) the free ligand 2, (B) the sodium picrate...
Figure 3: Schematic of the inclusion of alkali-metal ions (sodium and potassium) in the polar cavity defined ...
Beilstein J. Org. Chem. 2012, 8, 379–389, doi:10.3762/bjoc.8.41
Graphical Abstract
Figure 1: Structure and atomic numbering of 2,2’:6’,2’’-terpyridines.
Scheme 1: Synthesis of furanyl-substituted terpyridines 12–14 by using Kröhnke’s method.
Scheme 2: Synthesis of terpyridines under solvent-free conditions.
Scheme 3: Preparation of 4,4′,4′′-trisubstituted terpyridine containing carboxylate moieties.
Scheme 4: Synthetic pathway for the preparation of a furanyl-functionalised quinquepyridine.
Scheme 5: Utilization of an iminium salt in the preparation of a furanyl-substituted tpy.
Figure 2: Chemical structure of U- and S-shaped isomers.
Scheme 6: Preparation of an asymmetric furanyl-substituted terpyridine.
Scheme 7: Synthesis of tpy by Stille cross-coupling reaction.
Scheme 8: Oxidation of the furan ring of furanyl-substituted terpyridines.
Scheme 9: Direct oxidation of a furan ring attached on Ru(II) tpy complexes.
Figure 3: Example of polyoxometalate frameworks functionalised with tpy ligands and tpy-complex (reprinted wi...
Scheme 10: Synthetic pathway to europium(III) and samarium(III) chelates 56 and 57.
Scheme 11: Synthetic pathway to prepare thiocyanato-functionalised tpys as potential biomolecule-labelling age...
Scheme 12: Synthetic sequence envisioned for biomolecules labelling by click-chemistry.
Figure 4: Structure of pyrrolyl (66), thienyl (67) and bithienyl (68)-substituted complexes analogous to comp...
Beilstein J. Org. Chem. 2012, 8, 201–226, doi:10.3762/bjoc.8.22
Graphical Abstract
Figure 1: Calixarenes and expanded calixarenes: p-tert-Butylcalix[4]arene (1), p-tert-butyldihomooxacalix[4]a...
Figure 2: Conventional nomenclature for oxacalix[n]arenes.
Scheme 1: Synthesis of oxacalix[3]arenes: (i) Formaldehyde (37% aq), NaOH (aq), 1,4-dioxane; glacial acetic a...
Figure 3: p-tert-Butyloctahomotetraoxacalix[4]arene (4a) [16].
Figure 4: X-ray crystal structure of 3a showing phenolic hydrogen bonding (IUCr ID AS0508) [17].
Scheme 2: Stepwise synthesis of asymmetric oxacalix[3]arenes: (i) MOMCl, Adogen®464; (ii) 2,2-dimethoxypropan...
Figure 5: X-ray crystal structure of heptahomotetraoxacalix[3]arene 5 (CCDC ID 166088) [21].
Scheme 3: Oxacalix[3]arene synthesis by reductive coupling: (i) Me3SiOTf, Et3SiH, CH2Cl2; R1, R2 = I, Br, ben...
Scheme 4: Oxacalix[3]naphthalene: (i) HClO4 (aq), wet CHCl3 (R = tert-butyl, 6a, H, 6b) [20].
Figure 6: Conformers of 3a.
Scheme 5: Origin of the 25:75 cone:partial-cone statistical distribution of O-substituted oxacalix[3]arenes (p...
Scheme 6: Synthesis of alkyl ethers 7–10: (i) Alkyl halide, NaH, DMF [24].
Scheme 7: Synthesis of a pyridyl derivative 11a: (i) Picolyl chloride hydrochloride, NaH, DMF [26,27].
Figure 7: X-ray crystal structure of partial-cone 11a (CCDC ID 150580) [26].
Scheme 8: Lower-rim ethyl ester synthesis: (i) Ethyl bromoacetate, NaH, t-BuOK or alkali metal carbonate, THF...
Scheme 9: Forming chiral receptor 13: (i) Ethyl bromoacetate, NaH, THF; (ii) NaOH, H2O/1,4-dioxane; (iii) S-P...
Figure 8: X-ray crystal structure of 16 (IUCr ID PA1110) [32].
Scheme 10: Lower rim N,N-diethylamide 17a: (i) N,N-Diethylchloroacetamide, NaH, t-BuOK or alkali metal carbona...
Scheme 11: Capping the lower rim: (i) N,N-Diethylchloroacetamide, NaH, THF; (ii) NaOH, H2O/1,4-dioxane; (iii) ...
Figure 9: X-ray crystal structure of 18 (CCDC ID 142599) [33].
Scheme 12: Extending the lower rim: (i) Glycine methyl ester, HOBt, dicyclohexycarbodiimide (DCC), CH2Cl2; (ii...
Scheme 13: Synthesis of N-hydroxypyrazinone derivative 23: (i) 1-[3-(Dimethylamino)propyl]-3-ethylcarbodiimide...
Scheme 14: Synthesis of 24: (i) 1-Adamantyl bromomethyl ketone, NaH, THF [39].
Scheme 15: Synthesis of 25 and 26: (i) (Diphenylphosphino)methyl tosylate, NaH, toluene; (ii) phenylsilane, to...
Figure 10: X-ray crystal structure of 27 in the partial-cone conformer (CCDC ID SUP 90399) [41].
Scheme 16: Synthesis of strapped oxacalix[3]arene derivatives 28 and 29: (i) N,N’-Bis(chloroacetyl)-1,2-ethyle...
Figure 11: A chiral oxacalix[3]arene [45].
Figure 12: X-ray crystal structure of asymmetric oxacalix[3]arene 30 incorporating t-Bu, iPr and Et groups (CC...
Scheme 17: Reactions of an oxacalix[3]arene incorporating an upper-rim Br atom with (i) Pd(OAc)2, PPh3, HCO2H,...
Scheme 18: Synthesis of acid 39: (i) NaOH, EtOH/H2O, HCl (aq) [47].
Figure 13: Two forms of dimeric oxacalix[3]arene 40 [47].
Scheme 19: Capping the upper rim: (i) t-BuLi, THF, −78 °C; (ii) NaBH4, THF/EtOH; (iii) 1,3,5-tris(bromomethyl)...
Figure 14: Oxacalix[3]arene capsules 46 and 47 formed through coordination chemistry [52,53].
Figure 15: X-ray crystal structure of the 3b-vanadyl complex (CCDC ID 240185) [57].
Scheme 20: Effect of Ti(IV)/SiO2 on 3a: (i) Ti(OiPr)4, toluene; (ii) triphenylsilanol, toluene; (iii) partiall...
Figure 16: X-ray crystal structures of oxacalix[3]arene complexes with rhenium: 3b∙Re(CO)3 (CCDC ID 620981, le...
Figure 17: X-ray crystal structure of the La2·3a2 complex (CSD ID TIXXUT) [60].
Figure 18: X-ray crystal structures of [3a∙UO2]− with a cavity-bound cation (CCDC ID 135575, left) and without...
Figure 19: X-ray crystal structure of a supramolecule comprising two [3g·UO2]− complexes that encapsulate a di...
Figure 20: X-ray crystal structure of oxacalix[3]arene 49 capable of chiral selectivity (CSD ID HIGMUF) [65].
Figure 21: The structure of derivative 50 incorporating a Reichardt dye [66].
Figure 22: Phosphorylated oxacalix[3]arene complexes with transition metals: (Left to right) 26∙Au, 26∙Mo(CO)3...
Figure 23: X-ray crystal structure of [17a·HgCl2]2 (CCDC ID 168653) [69].
Figure 24: X-ray crystal structures of 3f with C60 (CCDC ID 182801, left) [76] and a 1,4-bis(9-fluorenyl) C60 deri...
Figure 25: X-Ray crystal structure of 3i and 6a encapsulating C60 (CCDC ID 102473 and 166077) [23,79].
Figure 26: A C60 complexing cationic oxacalix[3]arene 51 [81].
Figure 27: An oxacalix[3]arene-C60 self-associating system 53 [87].
Scheme 21: Synthesis of fluorescent pyrene derivative 55: (i) Propargyl bromide, acetone; (ii) CuI, 1-azidomet...
Scheme 22: Synthesis of responsive rhodamine derivative 57: (i) DCC, CH2Cl2 [91].
Scheme 23: Synthesis of nitrobenzyl derivative 58: (i) 1-Bromo-4-nitrobenzyl acetate, K2CO3, refluxing acetone...
Figure 28: X-ray crystal structure of [Na2∙17a](PF6)2 (CCDC ID 116656) [97].
Beilstein J. Org. Chem. 2011, 7, 1075–1094, doi:10.3762/bjoc.7.124
Graphical Abstract
Scheme 1: AuCl3-catalyzed benzannulations reported by Yamamoto.
Scheme 2: Synthesis of 9-oxabicyclo[3.3.1]nona-4,7-dienes from 1-oxo-4-oxy-5-ynes [40].
Scheme 3: Stereocontrolled oxacyclization/(4 + 2)-cycloaddition cascade of ketone–allene substrates [43].
Scheme 4: Gold-catalyzed synthesis of polycyclic, fully substituted furans from 1-(1-alkynyl)cyclopropyl keto...
Scheme 5: Gold-catalyzed 1,3-dipolar cycloaddition of 2-(1-alkynyl)-2-alken-1-ones with nitrones [47].
Scheme 6: Enantioselective 1,3-dipolar cycloaddition of 2-(1-alkynyl)-2-alken-1-ones with nitrones [48].
Scheme 7: Gold-catalyzed 1,3-dipolar cycloaddition of 2-(1-alkynyl)-2-alken-1-ones with α,β-unsaturated imine...
Scheme 8: Gold-catalyzed (4 + 3) cycloadditions of 1-(1-alkynyl)oxiranyl ketones [50].
Scheme 9: (3 + 2) Cycloaddition of gold-containing azomethine ylides [52].
Scheme 10: Gold-catalyzed generation and reaction of azomethine ylides [53].
Scheme 11: Gold-catalyzed intramolecular (4 + 2) cycloadditions of unactivated alkynes and dienes [55].
Scheme 12: Gold-catalyzed preparation of bicyclo[4.3.0]nonane derivatives from dienol silyl ethers [59].
Scheme 13: Gold(I)-catalyzed intramolecular (4 + 2) cycloadditions of arylalkynes or 1,3-enynes with alkenes [60].
Scheme 14: Gold(I)-catalyzed intermolecular (2 + 2) cycloaddition of alkynes with alkenes [62].
Scheme 15: Metal-catalyzed cycloaddition of alkynes tethered to cycloheptatriene [65].
Scheme 16: Gold-catalyzed cycloaddition of functionalized ketoenynes: Synthesis of (+)-orientalol F [68].
Scheme 17: Gold-catalyzed intermolecular cyclopropanation of enynes with alkenes [70].
Scheme 18: Gold-catalyzed intermolecular hetero-dehydro Diels–Alder cycloaddition [72].
Figure 1: Gold-catalyzed 1,2- or 1,3-acyloxy migrations of propargyl esters.
Scheme 19: Gold(I)-catalyzed stereoselective olefin cyclopropanation [74].
Scheme 20: Reaction of propargylic benzoates with α,β-unsaturated imines to give azepine cycloadducts [77].
Scheme 21: Gold-catalyzed (3 + 3) annulation of azomethine imines with propargyl esters [81].
Scheme 22: Gold(I)-catalyzed isomerization of 5-en-2-yn-1-yl acetates [83].
Scheme 23: (3 + 2) and (2 + 2) cycloadditions of indole-3-acetates 41 [85,86].
Scheme 24: Gold(I)-catalyzed (2 + 2) cycloaddition of allenenes [87].
Scheme 25: Formal (3 + 2) cycloaddition of allenyl MOM ethers and alkenes [90].
Scheme 26: (4 + 3) Cycloadditions of allenedienes [97,98].
Scheme 27: Gold-catalyzed transannular (4 + 3) cycloaddition reactions [101].
Scheme 28: Gold(I)-catalyzed (4 + 2) cycloadditions of allenedienes [102].
Scheme 29: Enantioselective gold(I)-catalyzed (4 + 2) cycloadditions of allenedienes [88,102,104].
Scheme 30: (3 + 2) versus (2 + 2) Cycloadditions of allenenes [87,99].
Figure 2: NHC ligands with different π-acceptor properties [106].
Scheme 31: (3 + 2) versus (2 + 2) Cycloadditions of allenenes [106].
Scheme 32: Gold(I)-catalyzed intermolecular (4 + 2) cycloaddition of allenamides and acyclic dienes [109].
Beilstein J. Org. Chem. 2011, 7, 1014–1020, doi:10.3762/bjoc.7.115
Graphical Abstract
Scheme 1: The counter ligands, an important factor in Au(I) catalysis.
Scheme 2: The challenge of the synthesis of allenes through gold activated alkynes.
Scheme 3: X-ray crystal structures of the two different types of 1,2,3-triazole–Au complexes.
Scheme 4: Synthesis of α-iodoenone compounds from propargyl esters.
Figure 1: Chemoselective activation of alkyne over allene by the TA–Au catalysts.
Beilstein J. Org. Chem. 2011, 7, 717–734, doi:10.3762/bjoc.7.82
Graphical Abstract
Scheme 1: General reactivity of cyclopropenes in the presence of gold catalysts.
Scheme 2: Cationic organogold species generated from cyclopropenone acetals.
Scheme 3: Rotation barriers around the C2–C3 bond (M06 DFT calculations).
Scheme 4: Au–C1 bond length in organogold species of type D.
Scheme 5: Gold-catalyzed addition of alcohols or water to cyclopropene 8.
Scheme 6: Gold-catalyzed addition of alcohols to cyclopropene 10.
Scheme 7: Mechanism of the gold-catalyzed addition of alcohols to cyclopropenes.
Scheme 8: Synthesis of tert-allylic ethers from cyclopropenes and allenes.
Scheme 9: Oxidation of the intermediate gold–carbene with diphenylsulfoxide.
Scheme 10: Gold, copper and Lewis acid-catalyzed reactions of cyclopropene 18.
Scheme 11: Mechanism of the Lewis acid-catalyzed reactions of cyclopropene 18.
Scheme 12: Gold-catalyzed rearrangement of vinylcyclopropenes 25.
Scheme 13: Gold-catalyzed rearrangement of cyclopropenes 27 to indenes 28.
Scheme 14: Gold-catalyzed rearrangement of cyclopropenes 29 to indenes 30.
Scheme 15: Gold-catalyzed rearrangement of cyclopropenyl ester 34a.
Scheme 16: Gold-catalyzed reactions of cyclopropenyl esters 34b–34d.
Scheme 17: Gold-catalyzed reactions of cyclopropenylsilane 34e.
Scheme 18: Gold-catalyzed rearrangement of cyclopropenylmethyl acetates.
Scheme 19: Mechanism of the gold-catalyzed rearrangement of cyclopropenes 39.
Scheme 20: Gold-catalyzed cyclopropanation of styrene with cyclopropene 8.
Scheme 21: Representative reactions of carbene precursors on gold metal.
Scheme 22: Intermolecular olefin cyclopropanation with gold carbenes generated from cyclopropenes.
Scheme 23: Gold-catalyzed formation of trienes from cyclopropenes and furans.
Scheme 24: Gold-catalyzed formation of trienes from cyclopropenes and furans.
Scheme 25: Gold-catalyzed formation of trienes from cyclopropenes and furans.
Scheme 26: Gold-catalyzed cycloisomerization of cyclopropene-ene 59.
Scheme 27: Gold-catalyzed cycloisomerization of substituted allyl cyclopropenyl carbinyl ethers 62a–62f.
Scheme 28: Gold-catalyzed cycloisomerization of cyclopropene-enes.
Scheme 29: Gold-catalyzed cycloisomerization of cyclopropene-ynes.
Scheme 30: Formation of products arising from a double cleavage process in the gold-catalyzed cycloisomerizati...
Scheme 31: Gold-catalyzed cycloisomerization of cyclopropene-ynes involving a double cleavage process.
Scheme 32: Gold-catalyzed reaction of cyclopropene-ynes, cyclopropene-enes and cyclopropene-allenes.
Beilstein J. Org. Chem. 2010, 6, 1174–1179, doi:10.3762/bjoc.6.134
Graphical Abstract
Scheme 1: Lipase-catalyzed acetylation of racemic benzylic secondary alcohol [(RS)-4] and its application.
Scheme 2: FeCl3-meditated synthesis of bis-imines.
Scheme 3: Preparation of racemic 3-(1-hydroxyethyl)phenyl ethyl(methyl)carbamate [(RS)-4]
Scheme 4: Proposed reaction mechanism of lipase-catalyzed acetylation of racemic alcohol 4.
Scheme 5: Complete synthesis of rivastigmine.
Beilstein J. Org. Chem. 2010, 6, 1106–1119, doi:10.3762/bjoc.6.127
Graphical Abstract
Scheme 1: Light activated metathesis of trans-2-pentene.
Scheme 2: Light induced generation of metathesis active species 2.
Figure 1: Well-defined tungsten photoactive catalysts.
Figure 2: The first ruthenium based complexes for PROMP.
Figure 3: Cyclic strained alkenes for PROMP.
Scheme 3: Proposed mechanism for photoactivation of sandwich complexes.
Figure 4: Ruthenium and osmium complexes with p-cymene and phosphane ligands for PROMP.
Figure 5: Commercially available photoactive ruthenium precatalyst.
Figure 6: Some of the rings produced by photo-RCM.
Scheme 4: Photopromoted ene-yne RCM by cationic allenylidene ruthenium complex 14.
Figure 7: Dihydrofurans synthesised by photopromoted ene-yne RCM.
Figure 8: Ruthenium complexes with p-cymene and NHC ligands.
Scheme 5: Ruthenium NHC complexes for PROMP containing p-cymene and trifluroacetate (17, 19) or phenylisonitr...
Figure 9: Photoactivated cationic ROMP precatalysts.
Figure 10: Different monomers for PROMP.
Scheme 6: Proposed mechanism for photoinitiated polymerisation by 22 and 23.
Figure 11: Light-induced cationic catalysts for ROMP.
Figure 12: Sulfur chelated ruthenium benzylidene pre-catalysts for olefin metathesis.
Scheme 7: Proposed mechanism for the photoactivation of sulfur-chelated ruthenium benzylidene.
Figure 13: Photoacid generators for photoinduced metathesis.
Scheme 8: Synthesis of precatalysts 36 and 37.
Scheme 9: Trapping of proposed intermediate 41.
Figure 14: Encapsulated 39, isolated from the monomer.
Beilstein J. Org. Chem. 2010, 6, No. 53, doi:10.3762/bjoc.6.53
Graphical Abstract
Scheme 1: Synthesis of twofold iodinated bis(benzo[b]thiophenyl)perfluorocyclopentene 4.
Scheme 2: Synthesis of terpyridinyl boronic acids 9a and 9b.
Scheme 3: Synthesis of the bis(terpyridinyl)diarylethenes 10a and 10b.
Scheme 4: Photochromic reaction of the free ligand 10a.
Figure 1: UV–vis-spectra of 10a before (solid), after UV-irradiation (dashed) and after irradiation with vis ...
Scheme 5: Synthesis of the binuclear Ru(II)-complex 12.
Figure 2: UV–vis-spectra of 12 before (solid), after UV-irradiation (dashed) and after irradiation with vis l...
Figure 3: UV–vis-spectra of 12 before (dashed), after UV-irradiation (dotted), the difference (solid) and fre...
Figure 4: UV–vis-spectra of [Fe2+@10a] before (solid), after UV-irradiation (dashed) and after irradiation wi...
Figure 5: UV–vis-spectra of [Zn2+@10a] before (solid), after UV-irradiation (dashed) and after irradiation wi...
Beilstein J. Org. Chem. 2010, 6, No. 32, doi:10.3762/bjoc.6.32
Graphical Abstract
Figure 1: Biologically important amines and quaternary ammonium salts: histamine (1), dopamine (2) and acetyl...
Figure 2: Crown ether 18-crown-6.
Figure 3: Conformations of 18-crown-6 (4) in solvents of different polarity.
Figure 4: Binding topologies of the ammonium ion depending on the crown ring size.
Figure 5: A “pseudorotaxane” structure consisting of 24-crown-8 and a secondary ammonium ion (5); R = Ph.
Figure 6: Typical examples of azacrown ethers, cryptands and related aza macrocycles.
Figure 7: Binding of ammonium to azacrown ethers and cryptands [111-113].
Figure 8: A 19-crown-6-ether with decalino blocking groups (11) and a thiazole-dibenzo-18-crown-6-ether (12).
Figure 9: 1,3-Bis(6-oxopyridazin-1-yl)propane derivatives 13 and 14 by Campayo et al.
Figure 10: Fluorescent azacrown-PET-sensors based on coumarin.
Figure 11: Two different pyridino-cryptands (17 and 18) compared to a pyridino-crown (19); chiral ammonium ion...
Figure 12: Pyridino-18-crown-6 ligand (21), a similar acridino-18-crown-6 ligand (22) and a structurally relat...
Figure 13: Ciral pyridine-azacrown ether receptors 24.
Figure 14: Chiral 15-crown-5 receptors 26 and an analogue 18-crown-6 ligand 27 derived from amino alcohols.
Figure 15: C2-symmetric chiral 18-crown-6 amino alcohol derivatives 28 and related macrocycles.
Figure 16: Macrocycles with diamide-diester groups (30).
Figure 17: C2-symmetric chiral aza-18-crown-6 ethers (31) with phenethylamine residues.
Figure 18: Chiral C-pivot p-methoxy-phenoxy-lariat ethers.
Figure 19: Chiral lariat crown ether 34.
Figure 20: Sucrose-based chiral crown ether receptors 36.
Figure 21: Permethylated fructooligosaccharide 37 showing induced-fit chiral recognition.
Figure 22: Biphenanthryl-18-crown-6 derivative 38.
Figure 23: Chiral lariat crown ethers derived from binol by Fuji et al.
Figure 24: Chiral phenolic crown ether 41 with “aryl chiral barriers” and guest amines.
Figure 25: Chiral bis-crown receptor 43 with a meso-ternaphthalene backbone.
Figure 26: Chromogenic pH-dependent bis-crown chemosensor 44 for diamines.
Figure 27: Triamine guests for binding to receptor 44.
Figure 28: Chiral bis-crown phenolphthalein chemosensors 46.
Figure 29: Crown ether amino acid 47.
Figure 30: Luminescent receptor 48 for bis-alkylammonium guests.
Figure 31: Luminescent CEAA (49a), a bis-CEAA receptor for amino acids (49b) and the structure of lysine bindi...
Figure 32: Luminescent CEAA tripeptide for binding small peptides.
Figure 33: Bis crown ether 51a self assembles co-operatively with C60-ammonium ion 51b.
Figure 34: Triptycene-based macrotricyclic dibenzo-[24]-crown-8 ether host 52 and guests.
Figure 35: Copper imido diacetic acid azacrown receptor 53a and the suggested His-Lys binding motif; a copper ...
Figure 36: Urea (54) and thiourea (55) benzo crown receptor for transport and extraction of amino acids.
Figure 37: Crown pyryliums ion receptors 56 for amino acids.
Figure 38: Ditopic sulfonamide bridged crown ether receptor 57.
Figure 39: Luminescent peptide receptor 58.
Figure 40: Luminescent receptor 59 for the detection of D-glucosamine hydrochloride in water/ethanol and lumin...
Figure 41: Guanidinium azacrown receptor 61 for simple amino acids and ditopic receptor 62 with crown ether an...
Figure 42: Chiral bicyclic guanidinium azacrown receptor 63 and similar receptor 64 for the enantioselective t...
Figure 43: Receptors for zwitterionic species based on luminescent CEAAs.
Figure 44: 1,10-Azacrown ethers with sugar podand arms and the anticancer agent busulfan.
Figure 45: Benzo-18-crown-6 modified β-cyclodextrin 69 and β-cyclodextrin functionalized with diaza-18-crown-6...
Figure 46: Receptors for colorimetric detection of primary and secondary ammonium ions.
Figure 47: Porphyrine-crown-receptors 72.
Figure 48: Porphyrin-crown ether conjugate 73 and fullerene-ammonium ion guest 74.
Figure 49: Calix[4]arene (75a), homooxocalix[4]arene (75b) and resorcin[4]arene (75c) compared (R = H, alkyl c...
Figure 50: Calix[4]arene and ammonium ion guest (R = H, alkyl, OAcyl etc.), possible binding sites; A: co-ordi...
Figure 51: Typical guests for studies with calixarenes and related molecules.
Figure 52: Lower rim modified p-tert-butylcalix[5]arenes 82.
Figure 53: The first example of a water soluble calixarene.
Figure 54: Sulfonated water soluble calix[n]arenes that bind ammonium ions.
Figure 55: Displacement assay for acetylcholine (3) with a sulfonato-calix[6]arene (84b).
Figure 56: Amino acid inclusion in p-sulfonatocalix[4]arene (84a).
Figure 57: Calixarene receptor family 86 with upper and lower rim functionalization.
Figure 58: Calix[6]arenes 87 with one carboxylic acid functionality.
Figure 59: Sulfonated calix[n]arenes with mono-substitution at the lower rim systematically studied on their r...
Figure 60: Cyclotetrachromotropylene host (91) and its binding to lysine (81c).
Figure 61: Calixarenes 92 and 93 with phosphonic acids groups.
Figure 62: Calix[4]arene tetraphosphonic acid (94a) and a double bridged analogue (94b).
Figure 63: Calix[4]arene tetraphosphonic acid ester (92c) for surface recognition experiments.
Figure 64: Calixarene receptors 95 with α-aminophosphonate groups.
Figure 65: A bridged homocalix[3]arene 95 and a distally bridged homocalix[4]crown 96.
Figure 66: Homocalix[3]arene ammonium ion receptor 97a and the Reichardt’s dye (97b) for colorimetric assays.
Figure 67: Chromogenic diazo-bridged calix[4]arene 98.
Figure 68: Calixarene receptor 99 by Huang et al.
Figure 69: Calixarenes 100 reported by Parisi et al.
Figure 70: Guest molecules for inclusion in calixarenes 100: DAP × 2 HCl (101a), APA (101b) and Lys-OMe × 2 HC...
Figure 71: Different N-linked peptido-calixarenes open and with glycol chain bridges.
Figure 72: (S)-1,1′-Bi-2-naphthol calixarene derivative 104 published by Kubo et al.
Figure 73: A chiral ammonium-ion receptor 105 based on the calix[4]arene skeleton.
Figure 74: R-/S-phenylalaninol functionalized calix[6]arenes 106a and 106b.
Figure 75: Capped homocalix[3]arene ammonium ion receptor 107.
Figure 76: Two C3 symmetric capped calix[6]arenes 108 and 109.
Figure 77: Phosphorous-containing rigidified calix[6]arene 110.
Figure 78: Calix[6]azacryptand 111.
Figure 79: Further substituted calix[6]azacryptands 112.
Figure 80: Resorcin[4]arene (75c) and the cavitands (113).
Figure 81: Tetrasulfonatomethylcalix[4]resorcinarene (114).
Figure 82: Resorcin[4]arenes (115a/b) and pyrogallo[4]arenes (115c, 116).
Figure 83: Displacement assay for acetylcholine (3) with tetracyanoresorcin[4]arene (117).
Figure 84: Tetramethoxy resorcinarene mono-crown-5 (118).
Figure 85: Components of a resorcinarene based displacement assay for ammonium ions.
Figure 86: Chiral basket resorcin[4]arenas 121.
Figure 87: Resorcinarenes with deeper cavitand structure (122).
Figure 88: Resorcinarene with partially open deeper cavitand structure (123).
Figure 89: Water-stabilized deep cavitands with partially structure (124, 125).
Figure 90: Charged cavitands 126 for tetralkylammonium ions.
Figure 91: Ditopic calix[4]arene receptor 127 capped with glycol chains.
Figure 92: A calix[5]arene dimer for diammonium salt recognition.
Figure 93: Calixarene parts 92c and 129 for the formation molecular capsules.
Figure 94: Encapsulation of a quaternary ammonium cation by two resorcin[4]arene molecules (NMe4+@[75c]2 × Cl−...
Figure 95: Encapsulation of a quaternary ammonium cation by six resorcin[4]arene molecules (NMe3D+@[130]6 × Cl−...
Figure 96: Structure and schematic of cucurbit[6]uril (CB[6], 131a).
Figure 97: Cyclohexanocucurbit[6]uril (CB′[6], 132) and the guest molecule spermine (133).
Figure 98: α,α,δ,δ-Tetramethylcucurbit[6]uril (134).
Figure 99: Structure of the cucurbituril-phthalhydrazide analogue 135.
Figure 100: Organic cavities for the displacement assay for amine differentiation.
Figure 101: Displacement assay methodology for diammonium- and related guests involving cucurbiturils and some ...
Figure 102: Nor-seco-Cucurbituril (±)-bis-ns-CB[6] (140) and guest molecules.
Figure 103: The cucurbit[6]uril based complexes 141 for chiral discrimination.
Figure 104: Cucurbit[7]uril (131c) and its ferrocene guests (142) opposed.
Figure 105: Cucurbit[7]uril (131c) guest inclusion and representative guests.
Figure 106: Cucurbit[7]uril (131c) binding to succinylcholine (145) and different bis-ammonium and bis-phosphon...
Figure 107: Paraquat-cucurbit[8]uril complex 149.
Figure 108: Gluconuril-based ammonium receptors 150.
Figure 109: Examples of clefts (151a), tweezers (151b, 151c, 151d) and clips (151e).
Figure 110: Kemp’s triacid (152a), on example of Rebek’s receptors (152b) and guests.
Figure 111: Amino acid receptor (154) by Rebek et al.
Figure 112: Hexagonal lattice designed hosts by Bell et al.
Figure 113: Bell’s amidinium receptor (156) and the amidinium ion (157).
Figure 114: Aromatic phosphonic acids.
Figure 115: Xylene phosphonates 159 and 160a/b for recognition of amines and amino alcohols.
Figure 116: Bisphosphonate recognition motif 161 for a colorimetric assay with alizarin complexone (163) for ca...
Figure 117: Bisphosphonate/phosphate clip 164 and bisphosphonate cleft 165.
Figure 118: N-Methylpyrazine 166a, N-methylnicotinamide iodide (166b) and NAD+ (166c).
Figure 119: Bisphosphate cavitands.
Figure 120: Bisphosphonate 167 of Schrader and Finocchiaro.
Figure 121: Tweezer 168 for noradrenaline (80b).
Figure 122: Different tripods and heparin (170).
Figure 123: Squaramide based receptors 172.
Figure 124: Cage like NH4+ receptor 173 of Kim et al.
Figure 125: Ammonium receptors 174 of Chin et al.
Figure 126: 2-Oxazolin-based ammonium receptors 175a–d and 176 by Ahn et al.
Figure 127: Racemic guest molecules 177.
Figure 128: Tripods based on a imidazole containing macrocycle (178) and the guest molecules employed in the st...
Figure 129: Ammonium ion receptor 180.
Figure 130: Tetraoxa[3.3.3.3]paracyclophanes 181 and a cyclophanic tetraester (182).
Figure 131: Peptidic bridged paraquat-cyclophane.
Figure 132: Shape-selective noradrenaline host.
Figure 133: Receptor 185 for binding of noradrenaline on surface layers from Schrader et al.
Figure 134: Tetraphosphonate receptor for binding of noradrenaline.
Figure 135: Tetraphosphonate 187 of Schrader and Finocchiaro.
Figure 136: Zinc-Porphyrin ammonium-ion receptors 188 and 189 of Mizutani et al.
Figure 137: Zinc porphyrin receptor 190.
Figure 138: Zinc porphyrin receptors 191 capable of amino acid binding.
Figure 139: Zinc-porphyrins with amino acid side chains for stereoinduction.
Figure 140: Bis-zinc-bis-porphyrin based on Tröger’s base 193.
Figure 141: BINAP-zinc-prophyrin derivative 194 and it’s guests.
Figure 142: Bisaryl-linked-zinc-porphyrin receptors.
Figure 143: Bis-zinc-porphyrin 199 for diamine recognition and guests.
Figure 144: Bis-zinc-porphyrin crown ether 201.
Figure 145: Bis-zinc-porphyrin 202 for stereodiscrimination (L = large substituent; S = small substituent).
Figure 146: Bis-zinc-porphyrin[3]rotaxane and its copper complex and guests.
Figure 147: Dien-bipyridyl ligand 206 for co-ordination of two metal atoms.
Figure 148: The ligand and corresponding tetradentate co-complex 207 serving as enantioselective receptor for a...
Figure 149: Bis(oxazoline)–copper(II) complex 208 for the recognition of amino acids in aqueous solution.
Figure 150: Zinc-salen-complexes 209 for the recognition tertiary amines.
Figure 151: Bis(oxazoline)–copper(II) 211 for the recognition of amino acids in aqueous solution.
Figure 152: Zn(II)-complex of a C2 terpyridine crown ether.
Figure 153: Displacement assay and receptor for aspartate over glutamate.
Figure 154: Chiral complex 214 for a colorimetric displacement assay for amino acids.
Figure 155: Metal complex receptor 215 with tripeptide side arms.
Figure 156: A sandwich complex 216 and its displaceable dye 217.
Figure 157: Lanthanide complexes 218–220 for amino acid recognition.
Figure 158: Nonactin (221), valinomycin (222) and vancomycin (223).
Figure 159: Monesin (224a) and a chiral analogue for enantiodiscrimination of ammonium guests (224b).
Figure 160: Chiral podands (226) compared to pentaglyme-dimethylether (225) and 18-crown-6 (4).
Figure 161: Lasalocid A (228).
Figure 162: Lasalocid derivatives (230) of Sessler et al.
Figure 163: The Coporphyrin I tetraanion (231).
Figure 164: Linear and cyclic peptides for ammonium ion recognition.
Figure 165: Cyclic and bicyclic depsipeptides for ammonium ion recognition.
Figure 166: α-Cyclodextrin (136a) and novocaine (236).
Figure 167: Helical diol receptor 237 by Reetz and Sostmann.
Figure 168: Ammonium binding spherand by Cram et al. (238a) and the cyclic[6]metaphenylacetylene 238b in compar...
Figure 169: Receptor for peptide backbone and ammonium binding (239).
Figure 170: Anion sensor principle with 3-hydroxy-2-naphthanilide of Jiang et al.
Figure 171: 7-bromo-3-hydroxy-N-(2-hydroxyphenyl)naphthalene 2-carboxamide (241) and its amine binding.
Figure 172: Naturally occurring catechins with affinity to quaternary ammonium ions.
Figure 173: Spiropyran (244) and merocyanine form (244a) of the amino acid receptors of Fuji et al.
Figure 174: Coumarin aldehyde (245) and its iminium species with amino acid bound (245a) by Glass et al.
Figure 175: Coumarin aldehyde appended with boronic acid.
Figure 176: Quinolone aldehyde dimers by Glass et al.
Figure 177: Chromogenic ammonium ion receptors with trifluoroacetophenone recognition motifs.
Figure 178: Chromogenic ammonium ion receptor with trifluoroacetophenone recognition motif bound on different m...
Beilstein J. Org. Chem. 2009, 5, No. 67, doi:10.3762/bjoc.5.67
Graphical Abstract
Figure 1: Definition of Asymmetric Catalyst Efficiency (ACE).
Beilstein J. Org. Chem. 2009, 5, No. 54, doi:10.3762/bjoc.5.54
Graphical Abstract
Figure 1: Molecular structure of NIRPAC: a Pd(II) complex based on Nile red and a curcumin derivative.
Figure 2: Molecular structure of Pd(II) complexes based on functionalised 2-phenylquinolines and β-diketonate...
Figure 3: Some unusual palladiomesogens based on 3,5-disubstituted-2,2′-pyridylpyrroles and β-diketonates.
Figure 4: Molecular structure of Pt(II) complexes based on 4,4′-disubstituted 2,2′-bipyridines.
Figure 5: Molecular structure of Zn(II) complexes based on polycatenar 4,4′-disubstituted 2,2′-bipyridines.
Figure 6: Molecular structure of a gallium(III) mesogen.